Jupiter 'Brain Coast' leaders talk discoveries, concerns over funding

Leaders from three Florida-based neuroscience institutes discussed groundbreaking research on brain health, including autism, neurodegeneration, and addiction, during a May 20 roundtable. They also highlighted concerns over reduced funding for biomedical sciences, which they say threatens progress in translating discoveries into real-world treatments.
Leaders from the Herbert Wertheim UF Scripps Institute, FAU Stiles-Nicholson Brain Institute, and Max Planck Florida Institute for Neuroscience participated in a May 20 roundtable hosted by the Palm Beach North Chamber of Commerce. The event, held at the Palm Beach Gardens Marriott, focused on advancements in neuroscience and the challenges of funding in Florida’s growing 'Brain Coast' cluster in Jupiter’s Abacoa neighborhood. Courtney Miller from Wertheim UF Scripps highlighted research into healthy forgetting mechanisms, neurodevelopmental disorders like autism, and neurodegeneration, including dementia. Her team also studies a protein linked to potential treatments for substance-use disorders, with plans to bring findings to clinical settings soon. Dr. Ken Dawson-Scully from FAU Stiles-Nicholson discussed early autism intervention methods and neurodegeneration research, including Alzheimer’s and Parkinson’s. His team also explores opioid addiction and studies temperature-resistant insects to uncover insights for human disease treatment. Dr. Joe Schumacher of Max Planck Florida Institute for Neuroscience emphasized synaptic plasticity and energy metabolism in the brain, noting discoveries like a protein complex with implications for neurodegeneration and learning disorders. He warned that decreased funding for biomedical sciences risks slowing progress in translating these findings into practical applications. Panelists agreed that collaboration between institutions and community engagement is critical to positioning Palm Beach County as a leader in brain health. A study by the Dana Foundation and Research America revealed that 80% of Americans face brain-health issues, underscoring the urgency of their work. The discussion also addressed broader funding challenges, with Schumacher noting that reduced support for biomedical research could hinder future breakthroughs in treating neurological and mental health conditions.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.